[1]
|
郑荣寿, 孙可欣, 张思维, 曾红梅, 邹小农, 陈茹, 顾秀瑛, 魏文强, 赫捷. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1): 19-28.
|
[2]
|
师金, 梁迪, 李道娟, 等. 全球女性乳腺癌流行情况研究[J]. 中国肿瘤, 2017, 26(9): 683-690.
|
[3]
|
陈万青, 郑荣寿. 中国女性乳腺癌发病死亡和生存状况[J]. 中国肿瘤临床, 2015, 42(13): 668-674.
|
[4]
|
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2011) Relevance of Breast Cancer Hormone Receptors and Other Factors to the Efficacy of Adjuvant Tamoxifen: Patient-Level Meta-Analysis of Randomised Trials. Lancet, 378, 771-784. https://doi.org/10.1016/S0140-6736(11)60993-8
|
[5]
|
Le Masters, T., Madhavan, S.S., Sambamoorthi, U., Hazard-Jenkins, H.W., Kelly, K.M. and Long, D. (2018) Receipt of Guideline-Concordant Care among Older Women with Stage I-III Breast Cancer: A Population-Based Study. Journal of the National Comprehensive Cancer Network, 16, 703-710. https://doi.org/10.6004/jnccn.2018.7004
|
[6]
|
宋延辉, 李晶, 吴涛, 冯晓冬, 罗丕福, 狄方. 70岁以上老年人乳腺浸润癌的临床病理分析[J]. 广东医学, 2019, 40(S1): 320-321+324.
|
[7]
|
Pappo, I., Karni, T. and Sandbank, J. (2007) Breast Cancer in the Elderly: Histological, Hormonal and Surgical Characteristics. Breast, 16, 60-67. https://doi.org/10.1016/j.breast.2006.05.007
|
[8]
|
Syed, B.M., Green, A.R. and Paish, E.C. (2013) Biology of Primary Breast Cancer in Older Women Treated by Surgery: With Correlation with Long-Term Clinical Outcome and Comparison with Their Younger Counterparts. British Journal of Cancer, 108, 1042-1051. https://doi.org/10.1038/bjc.2012.601
|
[9]
|
Wedding, U. and Höffken, K. (2003) Care of Breast Cancer in the Elderly Woman—What Does Comprehensive Geriatric Assessment (CGA) Help? Supportive Care in Cancer, 11, 769-774. https://doi.org/10.1007/s00520-003-0537-6
|
[10]
|
Gennari, R. and Audisio, R.A. (2008) Breast Cancer in Elderly Women. Optimizing the Treatment. Breast Cancer Research and Treatment, 110, 199-209. https://doi.org/10.1007/s10549-007-9723-4
|
[11]
|
Holmes, C.E. and Muss, H.B. (2003) Diagnosis and Treatment of Breast Cancer in the Elderly. CA: A Cancer Journal for Clinicians, 53, 227-244. https://doi.org/10.3322/canjclin.53.4.227
|
[12]
|
方谭玮, 俸瑞发, 陈威. 老年乳腺癌组织中表皮生长因子受体2、雌激素受体、孕酮受体、P53和Ki67的表达及其临床意义[J]. 中华老年医学杂志, 2017, 36(2): 173-176.
|
[13]
|
Tang, S.W., Parker, H., Winterbottom, L., Hassell, K., Ellis, I.O., Morgan, D.A. and Cheung, K.L. (2011) Early Primary Breast Cancer in the Elderly—Pattern of Presentation and Treatment. Surgical Oncology, 20, 7-12.
https://doi.org/10.1016/j.suronc.2009.07.004
|
[14]
|
Wallwiener, C.W., Hartkopf, A.D. and Grabe, E. (2016) Adjuvant Chemotherapy in Elderly Patients with Primary Breast Cancer: Are Women ≥65 Undertreated? Journal of Cancer Research and Clinical Oncology, 142, 1847-1853.
https://doi.org/10.1007/s00432-016-2194-4
|
[15]
|
Parks, R.M., Lakshmanan, R. and Winterbottom, L. (2012) Comprehensive Geriatric Assessment for Older Women with Early Breast Cancer—A Systematic Review of Literature. World Journal of Surgical Oncology, 10, Article No. 88. https://doi.org/10.1186/1477-7819-10-88
|
[16]
|
Kalsi, T., Babic-Illman, G. and Ross, P.J. (2015) The Impact of Comprehensive Geriatric Assessment Interventions on Tolerance to Chemotherapy in Older People. British Journal of Cancer, 112, 1435-1444.
https://doi.org/10.1038/bjc.2015.120
|
[17]
|
Decoster, L., Van Puyvelde, K. and Mohile, S. (2015) Screening Tools for Multidimensional Health Problems Warranting a Geriatric Assessment in Older Cancer Patients: An Update on SIOG Recommendations. Annals of Oncology, 26, 288-300. https://doi.org/10.1093/annonc/mdu210
|
[18]
|
De Santis, C., Siegel, R. and Bandi, P. (2011) Breast Cancer Statistics, 2011. CA: A Cancer Journal for Clinicians, 61, 409-418. https://doi.org/10.3322/caac.20134
|
[19]
|
Muss, H.B., Berry, D.A. and Cirrincione, C. (2007) Cancer and Leukemia Group B Experience. Toxicity of Older and Younger Patients Treated with Adjuvant Chemotherapy for Node-Positive Breast Cancer: The Cancer and Leukemia Group B Experience. Journal of Clinical Oncology, 25, 3699-3704. https://doi.org/10.1200/JCO.2007.10.9710
|
[20]
|
Zanuso, V., Fregoni, V., Gervaso, L. (2020) Side Effects of Adjuvant Chemotherapy and Their Impact on Outcome in Elderly Breast Cancer Patients: A Cohort Study. Future Science OA, 6, Article ID: FSO617.
https://doi.org/10.2144/fsoa-2020-0076
|
[21]
|
Muss, H.B., Berry, D.A., Cirrincione, C.T. and Theodoulou, M. (2009) Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer. New England Journal of Medicine, 360, 2055-2065.
https://doi.org/10.1056/NEJMoa0810266
|
[22]
|
Berry, D.A., Cirrincione, C. and Henderson, I.C. (2006) Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients with Node-Positive Breast Cancer. JAMA, 295, 1658-1667.
https://doi.org/10.1001/jama.295.14.1658
|
[23]
|
Jones, S., Holmes, F.A., O’Shaughnessy, J., et al., (2009) Docetaxel with Cyclophosphamide Is Associated with an Overall Survival Benefit Compared with Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735. Journal of Clinical Oncology, 27, 1177-1183. https://doi.org/10.1200/jco.2008.18.4028
|
[24]
|
Karavasilis, V., Papadimitriou, C., Gogas, H., et al. (2016) Safety and Tolerability of Anthracycline-Containing Adjuvant Chemotherapy in Elderly High-Risk Breast Cancer Patients. Clinical Breast Cancer, 16, 291-298.e3.
https://doi.org/10.1016/j.clbc.2015.12.001
|
[25]
|
Fisher, B., Dignam, J. and Bryant, J. (1996) Five versus More than Five Years of Tamoxifen Therapy for Breast Cancer Patients with Negative Lymph Nodes and Estrogen Receptor-Positive Tumors. Journal of the National Cancer Institute, 88, 1529-1542. https://doi.org/10.1093/jnci/88.21.1529
|
[26]
|
Santen, R.J. and Harvey, H.A. (1999) Use of Aromatase Inhibitors in Breast Carcinoma. Endocrine-Related Cancer, 6, 75-92. https://doi.org/10.1677/erc.0.0060075
|
[27]
|
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2015) Aromatase Inhibitors versus Tamoxifen in Early Breast Cancer: Patient-Level Meta-Analysis of the Randomised Trials. Lancet, 386, 1341-1352.
https://doi.org/10.1016/S0140-6736(15)61074-1
|
[28]
|
徐兵河, 张频. 绝经后早期乳腺癌芳香化酶抑制剂治疗相关的骨安全管理中国专家共识[J]. 中华肿瘤杂志, 2015, 37(7): 554-558.
|
[29]
|
Kunkler, I.H., Williams, L.J. and Jack, W.J. (2015) PRIME II Investigators. Breast-Conserving Surgery with or without Irradiation in Women Aged 65 Years or Older with Early Breast Cancer (PRIME II): A Randomised Controlled Trial. Lancet Oncology, 16, 266-273. https://doi.org/10.1016/S1470-2045(14)71221-5
|
[30]
|
Stueber, T.N. and Diessner, J. (2020) Effect of Adjuvant Radiotherapy in Elderly Patients with Breast Cancer. PLoS ONE, 15, e0229518. https://doi.org/10.1371/journal.pone.0229518
|
[31]
|
Molinaro, M., Ameri, P., Marone, G., et al. (2015) Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs. BioMed Research International, 2015, Article ID: 138148. https://doi.org/10.1155/2015/138148
|
[32]
|
Slamon, D.J., Leyland-Jones, B., Shak, S., et al. (2001) Use of Chemotherapy Plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2. New England Journal of Medicine, 344, 783-792.
https://doi.org/10.1056/NEJM200103153441101
|
[33]
|
Perez, E.A., Romond, E.H., Suman, V.J., et al. (2011) Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Joint Analysis of Data from NCCTG N9831 and NSABP B-31. Journal of Clinical Oncology, 29, 3366-3373.
https://doi.org/10.1200/JCO.2011.35.0868
|
[34]
|
Romond, E.H., Jeong, J.H., Rastogi, P., et al. (2012) Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) with ACP Plus Trastuzumab as Adjuvant Therapy for Patients with Node-Positive, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer. Journal of Clinical Oncology, 30, 3792-3799.
https://doi.org/10.1200/JCO.2011.40.0010
|
[35]
|
孙金波. 保乳联合前哨淋巴结活检治疗老年乳腺癌患者的疗效[J]. 中国医药指南, 2020, 18(22): 138-139.
|
[36]
|
马辉. 保乳术联合前哨淋巴结活检在老年乳腺癌患者治疗中的应用价值[J]. 中国老年学杂志, 2016, 36(19): 4805-4806.
|
[37]
|
陈军, 江强. 前哨淋巴结活检联合保乳手术治疗老年乳腺癌的临床疗效[J]. 中国老年学杂志, 2016, 36(24): 6151-6152.
|